Higher frequency of peripheral blood follicular regulatory T cells in patients with new onset ankylosing spondylitis

Follicular helper T (TFH) cells and B cells are linked to the pathogenesis of ankylosing spondylitis (AS). Follicular regulatory T (TFR) cells suppress TFH cell and germinal center B cell numbers in vivo. The role of TFR cells in AS is unknown. The frequency of peripheral blood inducible FOXP3+CXCR5+CD4+TFR cells and CXCR5+CD4+TFH cells were taken from 20 onset AS patients and 10 healthy controls, and were examined by flow cytometry, their disease activity were measured by the Bath Ankylosing Spondylitis Disease Activity Index. The concentrations of serum interleukin (IL)‐21, immunoglobulin G, immunoglobulin A, immunoglobulin M and C‐reactive protein were examined, and the values of erythrocyte sedimentation rate were measured. The frequency of peripheral blood FOXP3+CXCR5+CD4+TFR cells, CXCR5+CD4+TFH cells, the ratio of FOXP3+CXCR5+CD4+TFR/CXCR5+CD4+TFH cells and the concentration of serum IL‐21 in the AS patients were significantly higher than those in the healthy controls (P < 0.0001, P = 0.0027, P < 0.0001, P = 0.0039, respectively). The frequency of FOXP3+CXCR5+CD4+TFR cells and the ratio of FOXP3+CXCR5+CD4+TFR/CXCR5+CD4+TFH cells still significantly rose in those patients after standard treatment (P = 0.0006, P < 0.0001), the concentration of serum IL‐21 decreased after treatment (P = 0.0049), accompanied by significantly minimized disease activities. Furthermore, the TFR cells were negatively correlated with serum immunoglobulin A in those patients before treatment (r = −0.582, P = 0.0071), and the frequency of TFR cells was negatively correlated with that of TFH cells and the concentration of serum IL‐21 after treatment (r = −0.550, P = 0.046; r = −0.581, P = 0.0371). TFR cells might participate in the pathogenesis of AS, and might be responsible for controlling the autoantibodies, the frequency and function of TFH cells to inhibit the development of AS.

[1]  S. Hori Lineage stability and phenotypic plasticity of Foxp3+ regulatory T cells , 2014, Immunological reviews.

[2]  Yan-fang Jiang,et al.  Higher Frequency of Peripheral Blood Interleukin 21 Positive Follicular Helper T Cells in Patients with Ankylosing Spondylitis , 2013, The Journal of Rheumatology.

[3]  Carola G. Vinuesa,et al.  Foxp3(+) follicular regulatory T cells control the germinal centre response , 2012 .

[4]  V. Oliveira,et al.  Regulation of the Germinal Center Reaction by Foxp3+ Follicular Regulatory T Cells , 2011, The Journal of Immunology.

[5]  Paul Bowness,et al.  Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing Spondylitis* , 2011, Molecular & Cellular Proteomics.

[6]  Laurence A. Turka,et al.  Faculty Opinions recommendation of Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. , 2011 .

[7]  J. Niu,et al.  Th1 and Th2 Immune Response in Chronic Hepatitis B Patients during a Long-Term Treatment with Adefovir Dipivoxil , 2010, Mediators of inflammation.

[8]  Burton E. Barnett,et al.  Germinal Center T Follicular Helper Cell IL-4 Production Is Dependent on Signaling Lymphocytic Activation Molecule Receptor (CD150) , 2010, The Journal of Immunology.

[9]  Michael M. Ward,et al.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci , 2010, Nature Genetics.

[10]  Joshua LaBaer,et al.  Detection of Multiple Autoantibodies in Patients with Ankylosing Spondylitis Using Nucleic Acid Programmable Protein Arrays* , 2010, Molecular & Cellular Proteomics.

[11]  N. Tajik,et al.  Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients. , 2009, Iranian journal of allergy, asthma, and immunology.

[12]  C. Mackay,et al.  The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. , 2009, Immunity.

[13]  Burton E. Barnett,et al.  Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation , 2009, Science.

[14]  R. Nurieva,et al.  Bcl6 Mediates the Development of T Follicular Helper Cells , 2009, Science.

[15]  Zhiming Lin,et al.  Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis. , 2009, Chinese medical journal.

[16]  J. Goodall,et al.  Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[17]  M. Cook,et al.  Follicular helper T cells are required for systemic autoimmunity , 2009, The Journal of experimental medicine.

[18]  D. Otelea,et al.  Quantification and molecular characterization of regulatory T cells in connective tissue diseases , 2009, Autoimmunity.

[19]  N. Hotta,et al.  Deficiency of forkhead box P3 and cytotoxic T‐lymphocyte‐associated antigen‐4 gene expressions and impaired suppressor function of CD4+CD25+ T cells in patients with autoimmune hepatitis , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[20]  C. Kallenberg,et al.  Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. , 2007, Arthritis and rheumatism.

[21]  H. Dagfinrud,et al.  The Cochrane review of physiotherapy interventions for ankylosing spondylitis. , 2005, The Journal of rheumatology.

[22]  R. Copley,et al.  A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity , 2005, Nature.

[23]  S. Ziegler,et al.  FOXP3 acts as a rheostat of the immune response , 2005, Immunological reviews.

[24]  K. Mills,et al.  Regulatory T cells: friend or foe in immunity to infection? , 2004, Nature Reviews Immunology.

[25]  L. Sistonen,et al.  Enhanced intracellular replication of Salmonella enteritidis in HLA-B27-expressing human monocytic cells: dependency on glutamic acid at position 45 in the B pocket of HLA-B27. , 2004, Arthritis and rheumatism.

[26]  F. Ramsdell,et al.  An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.

[27]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[28]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[29]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[30]  M. Dougados,et al.  Conventional treatments for ankylosing spondylitis , 2002, Annals of the rheumatic diseases.

[31]  E. Wagner,et al.  Functions of AP1 (Fos/Jun) in bone development , 2002, Annals of the rheumatic diseases.

[32]  M. Ward,et al.  Medication toxicity among patients with ankylosing spondylitis. , 2002, Arthritis and rheumatism.

[33]  J J Anderson,et al.  Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. , 2001, Arthritis and rheumatism.

[34]  E. Butcher,et al.  Subspecialization of Cxcr5+ T Cells , 2001, The Journal of experimental medicine.

[35]  M. Pfreundschuh,et al.  B lymphocyte involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B lymphocytes from germinal center-like foci in the synovial membrane indicates antigen selection , 2001, Arthritis research.

[36]  J. Farrés,et al.  Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon γ is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies , 2000, Annals of the rheumatic diseases.

[37]  P Wordsworth,et al.  Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. , 1997, Arthritis and rheumatism.

[38]  A. Calin,et al.  A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. , 1994, The Journal of rheumatology.

[39]  M. Liang,et al.  Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. , 1994, The Journal of rheumatology.

[40]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[41]  E. L. Persons,et al.  Ankylosing Spondylitis , 1955, GP.

[42]  H. Redmond,et al.  Regulatory T-cells and autoimmunity. , 2006, The Journal of surgical research.

[43]  N. Lai,et al.  Two color analysis of HLA‐B27 antigen by flow cytometer—A comparative study by conventional microlymphocytoxicity, DNA genotyping polymerase chain reaction and flow cytometric measurement , 1997, Journal of clinical laboratory analysis.